Richard Vosser, a JPMorgan Chase & Co. analyst, predicts that the Bayer corporation may have to pay more than $2.65 billion to resolve all the cases over its Yasmin line of birth control pills, Bloomberg reports.
Vosser made his prediction after the German drug-maker settled 651 cases over allegations that the contraceptives caused blood clots, some of which were fatal. In its Stockholders Newsletter, the company said it paid $142 million ...
continue reading...